AtriCure Director Maggie Yuen Sells 3,500 Shares

What Happened
Maggie Yuen, a director of AtriCure, sold 3,500 shares of ATRC in an open-market transaction on August 5, 2026. The weighted average sale price reported was $38.42 per share, for aggregate proceeds of approximately $134,470. This filing reports a sale (code S), which is a disposition of existing holdings rather than a purchase or option exercise.

Key Details

• Transaction date: 2026-08-05; Form 4 filed: 2026-08-07 (appears within the normal 2-business-day reporting window).
• Price: weighted average $38.42; per-footnote, executed in multiple trades at prices ranging $38.37–$38.43.
• Shares sold: 3,500; proceeds ≈ $134,470.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: reporting person offers to provide, upon request, full details of the number of shares and exact prices for each trade.
• Transaction type: open-market sale (disposition), reporting code S. No 10b5-1 plan, tax withholding, or option exercise was disclosed.

Context: Sales by directors can be routine (portfolio rebalancing, diversification, personal needs) and do not by themselves indicate company performance. Because this was a straight sale of existing shares and not an acquisition, it is generally less informative about insider sentiment than purchases.